Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arsenic Trioxide in Advanced Hormone-Refractory Prostate Cancer
NCT00004149Phase 2Completed
- Sponsor
- Albert Einstein College of Medicine
- Start
- Sep 1999
- Primary completion
- Aug 2003
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of arsenic trioxide in prostate cancer (PCa), sponsored by Albert Einstein College of Medicine. Started Sep 1999; status: completed.
02
Drugs
arsenic trioxide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00004149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004149.